Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Frustration Drives Japan To Allow Generics Before Side Patents Expire

This article was originally published in PharmAsia News

Executive Summary

TOKYO - In a continuing effort to raise generic drug use, Japan's Ministry of Health, Labor and Welfare has decided to allow generic drugs to be manufactured even before brand drugs' side patents expire, the ministry's Insurance Bureau officials said
Advertisement

Related Content

Wide Data Gap On Generics Use In Japan Puts Damper On MHLW 30% Generic Target
Wide Data Gap On Generics Use In Japan Puts Damper On MHLW 30% Generic Target
Battling Negative Image Of Generics In Japan (Part 2 of 2)
Japanese Pharmas Agree To Lower NHI Prices When Generic Uptake Is Slow
Advertisement
UsernamePublicRestriction

Register

SC071427

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel